Results 81 to 90 of about 5,544 (172)

Surprising safety outcomes of urate-lowering therapy [PDF]

Nature Reviews Rheumatology, 2018
openaire   +2 more sources

The Uric Acid Dilemma: A Nutritional Odyssey

Annals of Rheumatology and Autoimmunity
Gout prevalence continues to rise worldwide, with an estimated 53.9 million cases in 2019, representing a 22% increase in age-standardized prevalence compared to 1990. Although urate-lowering pharmacotherapy remains the cornerstone of management, dietary
Muhammed Jasim Abdul Jalal
doaj   +1 more source

Beliefs of rheumatologists and general practitioners on urate lowering therapy: a cross-sectional study. [PDF]

Rheumatol Adv Pract, 2023
Veenstra F, Vriezekolk JE, van den Bemt BJF, Schers HJ, Sloot B, van den Ende CHM, van Herwaarden N, Flendrie M.   +7 more
europepmc   +1 more source

Treat-to-target urate-lowering therapy and hospitalizations for gout: results from a nationwide cohort study in England. [PDF]

Rheumatology (Oxford), 2023
Russell MD, Roddy E, Rutherford AI, Ellis B, Norton S, Douiri A, Gulliford MC, Cope AP, Galloway JB.   +8 more
europepmc   +1 more source

Persistence with urate-lowering therapy in Australia: A longitudinal analysis of allopurinol prescriptions. [PDF]

Br J Clin Pharmacol, 2022
Coleshill MJ, Day RO, Tam K, Kouhkamari M, Caillet V, Aung E, Kannangara DRW, Cronin P, Rodgers A, Stocker SL.   +9 more
europepmc   +1 more source

Factors for achieving target serum uric acid levels after initiating urate-lowering therapy in patients with gout: results from the ULTRA registry. [PDF]

Sci Rep, 2023
Do H, Choi HJ, Choi B, Son CN, Kim SH, Choi SR, Kim JH, Kim MJ, Shin K, Kim HO, Song R, Lee SW, Ahn JK, Lee SG, Lee CH, Son KM, Moon KW.   +16 more
europepmc   +1 more source

Initiation of Urate Lowering Therapy (ULT)

The Singapore Family Physician, 2019
Meng Kam Richard Lee, Yee Nah Anita Lim
openaire   +2 more sources

Elevated serum CA72-4 predicts gout flares during urate lowering therapy initiation: a prospective cohort study. [PDF]

Rheumatology (Oxford), 2023
Hu S, Sun M, Li M, Xue X, Terkeltaub R, Wang C, Wang M, Lu J, Ran Z, Li H, Ji A, Sun W, Li X, He Y, Liu Z, Zhang H, Wang X, Ji X, Dalbeth N, Li C.   +19 more
europepmc   +1 more source

When underlying biology threatens the randomization principle - initial gout flares of urate-lowering therapy. [PDF]

Nat Rev Rheumatol, 2022
Choi HK, Zhang Y, Dalbeth N.
europepmc   +1 more source

Treatment sequence patterns of urate-lowering therapy in Korean patients with gout: A common data model-based study. [PDF]

PLoS One
Kim MJ, Park EG, Kim C, Kang DY, Ryu B, Shin K.   +5 more
europepmc   +1 more source